Cargando…
Improving the treatment of childhood acute lymphoblastic leukemia by optimizing the use of 70-year-old drugs
Autor principal: | Evans, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561287/ https://www.ncbi.nlm.nih.gov/pubmed/34047180 http://dx.doi.org/10.3324/haematol.2021.278967 |
Ejemplares similares
-
Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
por: Conter, Valentino, et al.
Publicado: (2021) -
The Microbiome in Childhood Acute Lymphoblastic Leukemia
por: Oldenburg, Marina, et al.
Publicado: (2021) -
Improving the Treatment of Acute Lymphoblastic Leukemia
por: Radadiya, Ashish, et al.
Publicado: (2020) -
Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia
por: Aberuyi, Narges, et al.
Publicado: (2020) -
Recent Advances in Treatment Options for Childhood Acute Lymphoblastic Leukemia
por: Malczewska, Marta, et al.
Publicado: (2022)